Huiying Sun

1838 North Guangzhou Avenue
Guangzhou, 510515, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Corrigendum to Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer [iScience Volume 29, Issue 3, March 2026, Article e114872].

Corrigendum to Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer [iScience Volume 29, Issue 3, March 2026, Article e114872].

Journal: iScience

Published: July 02, 2026

Endothelial F3-mediated autolysosome and lipid metabolism promote resistance to anti-VEGFA therapy in metastatic colorectal cancer.

Endothelial F3-mediated autolysosome and lipid metabolism promote resistance to anti-VEGFA therapy in metastatic colorectal cancer.

Journal: Autophagy

Published: September 09, 2025

Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials.

Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 02, 2025

Immunotyping the Tumor Microenvironment Reveals Molecular Heterogeneity for Personalized Immunotherapy in Cancer.

Immunotyping the Tumor Microenvironment Reveals Molecular Heterogeneity for Personalized Immunotherapy in Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 26, 2024

Neutrophil-to-lymphocyte ratio-based prognostic score can predict outcomes in patients with advanced non-small cell lung cancer treated with immunotherapy plus chemotherapy.

Neutrophil-to-lymphocyte ratio-based prognostic score can predict outcomes in patients with advanced non-small cell lung cancer treated with immunotherapy plus chemotherapy.

Journal: BMC cancer

Published: October 21, 2024

Artificial Intelligence-Based Multimodal Prediction of Postoperative Adjuvant Immunotherapy Benefit in Urothelial Carcinoma: Results From the Phase III, Multicenter, Randomized, IMvigor010 Trial.

Artificial Intelligence-Based Multimodal Prediction of Postoperative Adjuvant Immunotherapy Benefit in Urothelial Carcinoma: Results From the Phase III, Multicenter, Randomized, IMvigor010 Trial.

Journal: MedComm

Published: September 26, 2024

Dynamic single-cell sequencing unveils the tumor microenvironment evolution of gastric cancer abdominal wall metastases during radiotherapy.

Dynamic single-cell sequencing unveils the tumor microenvironment evolution of gastric cancer abdominal wall metastases during radiotherapy.

Journal: Cancer science

Published: March 29, 2024

Tumor microenvironment RNA test to predict immunotherapy outcomes in advanced gastric cancer: The TIMES001 trial.

Tumor microenvironment RNA test to predict immunotherapy outcomes in advanced gastric cancer: The TIMES001 trial.

Journal: Med (New York, N.Y.)

Published: February 06, 2024

Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer.

Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer.

Journal: iScience

Published: October 19, 2023

Co-expression pattern of SLC transporter genes associated with the immune landscape and clinical outcomes in gastric cancer.

Co-expression pattern of SLC transporter genes associated with the immune landscape and clinical outcomes in gastric cancer.

Journal: Journal of cellular and molecular medicine

Published: May 30, 2023

High baseline tumor burden-associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2-STAT3-PD-L1 pathway.

High baseline tumor burden-associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2-STAT3-PD-L1 pathway.

Journal: Cancer communications (London, England)

Published: January 26, 2023

Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases.

Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases.

Journal: Cancer research

Published: January 03, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026